KR101855737B1 - Aroma composition with buleberry flavor for relaxation and uses thereof - Google Patents
Aroma composition with buleberry flavor for relaxation and uses thereof Download PDFInfo
- Publication number
- KR101855737B1 KR101855737B1 KR1020160119745A KR20160119745A KR101855737B1 KR 101855737 B1 KR101855737 B1 KR 101855737B1 KR 1020160119745 A KR1020160119745 A KR 1020160119745A KR 20160119745 A KR20160119745 A KR 20160119745A KR 101855737 B1 KR101855737 B1 KR 101855737B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- inhalation
- acetate
- ethyl
- power spectrum
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 239000000796 flavoring agent Substances 0.000 title claims description 27
- 235000019634 flavors Nutrition 0.000 title claims description 27
- 238000001228 spectrum Methods 0.000 claims abstract description 50
- 239000002304 perfume Substances 0.000 claims abstract description 29
- 210000001652 frontal lobe Anatomy 0.000 claims abstract description 26
- 210000001152 parietal lobe Anatomy 0.000 claims abstract description 14
- 230000002360 prefrontal effect Effects 0.000 claims abstract description 14
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 235000013376 functional food Nutrition 0.000 claims abstract description 9
- 230000036541 health Effects 0.000 claims abstract description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 16
- 210000003478 temporal lobe Anatomy 0.000 claims description 15
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 claims description 14
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 claims description 14
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 claims description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000006071 cream Substances 0.000 claims description 12
- PHXATPHONSXBIL-UHFFFAOYSA-N xi-gamma-Undecalactone Chemical compound CCCCCCCC1CCC(=O)O1 PHXATPHONSXBIL-UHFFFAOYSA-N 0.000 claims description 12
- 239000006210 lotion Substances 0.000 claims description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 claims description 10
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims description 10
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 claims description 10
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 10
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 8
- 239000000686 essence Substances 0.000 claims description 8
- 229940093503 ethyl maltol Drugs 0.000 claims description 8
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 claims description 8
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 8
- 235000016709 nutrition Nutrition 0.000 claims description 8
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 claims description 8
- 229940090181 propyl acetate Drugs 0.000 claims description 8
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 claims description 8
- 229960002622 triacetin Drugs 0.000 claims description 8
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 8
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 claims description 7
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 7
- 150000001241 acetals Chemical class 0.000 claims description 7
- 229940116333 ethyl lactate Drugs 0.000 claims description 7
- 229940073505 ethyl vanillin Drugs 0.000 claims description 7
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 claims description 7
- 239000004310 lactic acid Substances 0.000 claims description 7
- 235000014655 lactic acid Nutrition 0.000 claims description 7
- 229940043353 maltol Drugs 0.000 claims description 7
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 6
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 6
- PHXATPHONSXBIL-JTQLQIEISA-N gamma-Undecalactone Natural products CCCCCCC[C@H]1CCC(=O)O1 PHXATPHONSXBIL-JTQLQIEISA-N 0.000 claims description 6
- 229940020436 gamma-undecalactone Drugs 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 6
- 239000001069 triethyl citrate Substances 0.000 claims description 6
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 6
- 235000013769 triethyl citrate Nutrition 0.000 claims description 6
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 claims description 5
- SHSGYHAHMQLYRB-UHFFFAOYSA-N 2-Methyl-1-phenyl-2-propanyl butyrate Chemical compound CCCC(=O)OC(C)(C)CC1=CC=CC=C1 SHSGYHAHMQLYRB-UHFFFAOYSA-N 0.000 claims description 5
- 229940007550 benzyl acetate Drugs 0.000 claims description 5
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 claims description 5
- 229940117955 isoamyl acetate Drugs 0.000 claims description 5
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920002230 Pectic acid Polymers 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 235000014171 carbonated beverage Nutrition 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 claims description 2
- 239000010318 polygalacturonic acid Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000004902 Softening Agent Substances 0.000 claims 1
- 235000013334 alcoholic beverage Nutrition 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 abstract description 53
- 235000017537 Vaccinium myrtillus Nutrition 0.000 abstract description 53
- 235000021014 blueberries Nutrition 0.000 abstract description 53
- 240000000851 Vaccinium corymbosum Species 0.000 abstract description 49
- 239000003205 fragrance Substances 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 17
- 235000020831 absolute fast Nutrition 0.000 abstract description 6
- 210000004556 brain Anatomy 0.000 description 31
- 235000013305 food Nutrition 0.000 description 16
- 235000013599 spices Nutrition 0.000 description 14
- 238000013507 mapping Methods 0.000 description 7
- 210000002442 prefrontal cortex Anatomy 0.000 description 7
- 230000003595 spectral effect Effects 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- 230000007177 brain activity Effects 0.000 description 6
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 6
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 6
- 235000012141 vanillin Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 244000077233 Vaccinium uliginosum Species 0.000 description 4
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 4
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 230000037007 arousal Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 210000003710 cerebral cortex Anatomy 0.000 description 3
- 230000001149 cognitive effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012353 t test Methods 0.000 description 3
- 229940117960 vanillin Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 description 2
- 101710128386 Rho guanine nucleotide exchange factor 4 Proteins 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003920 cognitive function Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 210000005153 frontal cortex Anatomy 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 210000001103 thalamus Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 1
- DHXFNHQWXMSCBB-UHFFFAOYSA-N 3-ethyl-4-hydroxyheptane-2,3,4-tricarboxylic acid;triethyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC.CCC(C(O)=O)C(O)(C(O)=O)C(CC)(CC)C(O)=O DHXFNHQWXMSCBB-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- WERLCVLDMOINSQ-UHFFFAOYSA-N 3-methylbutyl acetate 5-methylhexanoic acid Chemical compound CC(C)CCCC(O)=O.CC(C)CCOC(C)=O WERLCVLDMOINSQ-UHFFFAOYSA-N 0.000 description 1
- DUUGKQCEGZLZNO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Chemical compound C1=C(O)C=C2C(CC(=O)O)=CNC2=C1 DUUGKQCEGZLZNO-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- ZVQUYMKKXHCGGQ-UHFFFAOYSA-N CC(=O)OCC1=CC=CC=C1.OC(=O)CCC1=CC=CC=C1 Chemical compound CC(=O)OCC1=CC=CC=C1.OC(=O)CCC1=CC=CC=C1 ZVQUYMKKXHCGGQ-UHFFFAOYSA-N 0.000 description 1
- FTJSZJRZIKNLHY-UHFFFAOYSA-N CCCCC(O)=O.CCCOC(C)=O Chemical compound CCCCC(O)=O.CCCOC(C)=O FTJSZJRZIKNLHY-UHFFFAOYSA-N 0.000 description 1
- LCZGGWFMHDNYOT-UHFFFAOYSA-N CCCOC(C)=O.CCCOC(C)=O Chemical compound CCCOC(C)=O.CCCOC(C)=O LCZGGWFMHDNYOT-UHFFFAOYSA-N 0.000 description 1
- GSINYWZNQFOYPT-UHFFFAOYSA-N CCOC(=O)CC.CCC(C)C(O)=O Chemical compound CCOC(=O)CC.CCC(C)C(O)=O GSINYWZNQFOYPT-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000699700 Ondatra zibethicus Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229940057971 butane Drugs 0.000 description 1
- -1 butano (butano) l Chemical compound 0.000 description 1
- HTRXGEPDTFSKLI-UHFFFAOYSA-N butanoic acid;ethyl acetate Chemical compound CCCC(O)=O.CCOC(C)=O HTRXGEPDTFSKLI-UHFFFAOYSA-N 0.000 description 1
- BRDOFYPYQFDHOQ-UHFFFAOYSA-N butyl acetate;hexanoic acid Chemical compound CCCCCC(O)=O.CCCCOC(C)=O BRDOFYPYQFDHOQ-UHFFFAOYSA-N 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000008909 emotion recognition Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- QBOZJTVVSXHSEK-UHFFFAOYSA-N ethyl butanoate Chemical compound CCCC(=O)OCC.CCCC(=O)OCC QBOZJTVVSXHSEK-UHFFFAOYSA-N 0.000 description 1
- SSAHOVVSGAUNEL-UHFFFAOYSA-N ethyl butanoate;2-ethylbutanoic acid Chemical compound CCCC(=O)OCC.CCC(CC)C(O)=O SSAHOVVSGAUNEL-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 210000002617 middle hypothalamus Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 210000001706 olfactory mucosa Anatomy 0.000 description 1
- 210000002475 olfactory pathway Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 긴장완화용 블루베리향 향료 조성물, 상기 향료 조성물을 포함하는 긴장완화용 건강기능식품 및 화장료 조성물에 관한 것으로, 본 발명의 향료 조성물은 향료 흡입 시, 좌측과 우측 전전두엽, 좌측과 우측 전두엽, 그리고 우측 측두엽에서 RFA(Relative Fast Alpha power spectrum)의 증가를, 좌측 및 우측 전전두엽과 좌측 및 우측 전두엽에서 AFA(Absolute Fast Alpha power spectrum)의 증가를, 그리고 우측 두정엽에서 AT(Absolute Theta power spectrum)의 증가를 유도하여 긴장완화 효과가 있다.The present invention relates to a blueberries fragrance composition for relieving tension, a health functional food and a cosmetic composition for relieving tensions comprising the fragrance composition, wherein the perfume composition of the present invention contains, when perfume is inhaled, the left and right prefrontal, And Absolute Theta power spectrum (AT) in the right parietal lobe, and increase in the absolute fast alpha power spectrum (AFA) in the left and right prefrontal and left and right frontal lobes, Which is an effect of relaxation.
Description
본 발명은 긴장완화용 블루베리향 향료 조성물 및 이의 용도에 관한 것이다.The present invention relates to a blueberries fragrance composition for relaxation and to its use.
식품향료란 식품을 향기롭게 하거나 냄새를 없애기 위해서 첨가하는 것으로, 식품에 있어서 독특한 개성과 품위 그리고 매력을 주어 상품의 가치를 높이는 첨가물이다.Food flavor is added to scent food or to eliminate odor. It is an additive that enhances the value of a product by giving it a unique personality, elegance and charm.
식품향료는 향료를 얻는 기원에 따라 천연향료와 합성향료로 구분되는데 천연향료는 식물ㆍ동물로부터 얻어지는 향료로, 동물로부터 얻어지는 천연향료는 무스크(musk), 시빗(civet), 카스토레움(castoreum), 앰버그리스(ambergris), 무스크 래트(musk rat) 등 매우 제한적이어서 현재 식품에 사용되는 천연향료는 대부분 식물로부터 얻어진 것이다. 합성향료는 유기화합물을 화학적 방법으로 합성하여 얻어진다.Food fragrances are classified into natural fragrances and synthetic fragrances depending on the origin of the fragrance. Natural fragrances are fragrances obtained from plants and animals. Natural fragrances obtained from animals include musk, civet, castorum, , Ambergris, musk rat and the like, and the natural flavors used in the present foods are mostly derived from plants. Synthetic fragrance is obtained by chemical synthesis of organic compounds.
또한, 식품향료는 그 용매에 따라 수용성향료, 유용성향료, 유화향료, 분말향료로 분류된다. 수용성향료는 원래 물에 잘 녹지 않는 향료를 알코올과 프로필렌글리콜(propylene glycol, PG)을 이용하여 물에 잘 용해되도록 조제한 것으로 주로 청량음료, 빙과, 제과 등에 사용되는데 휘발성이 강한 특징이 있어서 가열처리 가공하는 식품에 사용하기에는 적당하지 않다. 유용성향료는 향료를 식물성기름과 합성기름에 용해시킨 것과 PG, 글리세린(glycerine) 등의 비등점이 높은 용매에 용해시킨 것이다. 유화향료는 내열성이 강하여 쿠키, 캔디, 양과자 등 열처리하는 식품에 사용되는데 일반적으로 수용성향료에 비해 향미가 약한 특징을 가지며, 분말향료는 천연검, 전분 등과 같은 부형제에 향료를 분무, 건조시켜 미세한 분말로 만든 것으로, 향료가 부형제에 둘러 싸여 있기 때문에 공기와의 접촉이 적어 산화에 대해 안전하여 분말식품 등에 사용된다. 그러나 제조공정에서 가열처리를 해야 하므로 신선미가 부족하게 되는 단점도 있다.In addition, food flavorings are classified into water-soluble flavors, oil-soluble flavors, oil-based flavors and powder flavors, depending on the solvent. The water-soluble fragrance is prepared by dissolving spice which is not soluble in water in water by using alcohol and propylene glycol (PG). It is mainly used for soft drinks, ice cream, confectionery, etc. It is characterized by high volatility. It is not suitable for use in food. Oil-soluble fragrances are fragrances dissolved in vegetable oils and synthetic oils, and dissolved in solvents with high boiling points such as PG and glycerine. The emulsion fragrance is strong in heat resistance and is used in foods which are heat treated such as cookies, candies, confectionery, etc. Generally, the flavor is weaker than the water-soluble flavor. The powder flavor is sprayed on the excipient such as natural gum and starch, , Because fragrance is surrounded by excipients, it is safe for oxidation because of low contact with air and is used in powdered foods and so on. However, there is a disadvantage that the freshness is insufficient because the heat treatment must be performed in the manufacturing process.
식품향료가 함유된 식품을 치아로 잘게 부수거나 혹은 음료를 마셨을 때 식품에 함유되어 있는 향료 조성물은 호기 시에 폐를 타고 올라온 공기와 만나 비강으로 이동하는데 이때 비강에 위치한 후각상피에 도달하게 된다. 후각상피에 있는 후각신경세포가 향료 조성물을 감지하여 뇌에 전기적인 신호를 전달하는 것으로 알려져 있으며, 후각신경세포에서 발생한 신호는 후각망울(olfactory bulb)에서 해석된 후, 두 가지 후각신호 전달경로를 통해 뇌 전반에 전기적 신호를 전달하는데 하나는 시상(thalamus)을 거치지 않고 편도핵(amygdala)과 가측 시상하부를 거쳐 대뇌피질로 전달되는 경로이고, 또 다른 하나는 후각피질(조롱박피질, pyriform cortex)을 거치는 경로로 시상을 거쳐 대뇌피질로 전달되는 경로이다.The fragrance composition contained in the food when the food containing the fragrant food is finely crushed or drunk is met with the air raised in the lung at the time of expiration and moves to the nasal cavity at this time, It is known that the olfactory neurons in the olfactory epithelium transmit electrical signals to the brain by sensing the perfume composition. The signals from the olfactory neurons are analyzed in the olfactory bulb, and two olfactory signal pathways (Amygdala) and the medial hypothalamus through the cerebral cortex without passing through the thalamus, and the other is the pathway through which the olfactory cortex (pyriform cortex) It is a pathway that passes through the thalamus to the cerebral cortex.
2014년 식품의약안전처의 건강기능식품 기능성 평가 가이드 '긴장완화에 도움을 줄 수 있음 편'에 따르면 식품에 함유된 휘발성 유기화합물로 구성된 향료가 뇌에 영향을 미치는 것을 확인하기 위한 기전으로는 생리적 지표, 행동적 지표, 심리적 지표를 들고 있다. 지표별로 기능성 확인을 위한 바이오마커가 제시되어 있는데 인체적용시험으로는 세로토닌(serotonin), 5-HIAA(5-hydroxy indolacetic acid), 도파민(dopamin), DOPAC(3,4-dihydroxy phenyl acetic acid), HVA(homovanillic acid), 노르에피네프린(norepinephrine), 코르티솔(cortisol), 부신피질자극 호르몬, 타액 아밀라아제(salivary amylase), 타액 IgA, 혈압 측정, 심박수 측정, 뇌파 측정을 들 수 있다.In 2014, the Food and Drug Administration's Guide to Functional Food Functional Assessment, "Can Help Strain Relief," suggests that mechanisms to determine that spices composed of volatile organic compounds in foods affect the brain include physiological Indicators, behavioral indicators, and psychological indicators. Biomarkers for functional confirmation are presented on each indicator. Serotonin, 5-hydroxy indolacetic acid, dopamine, 3,4-dihydroxy phenyl acetic acid (DOPAC) HVA (homovanillic acid), norepinephrine, cortisol, corticosteroids, salivary amylase, saliva IgA, blood pressure measurement, heart rate measurement, and brain wave measurement.
건강기능식품의 기능성을 평가하는 바이오마커 중 하나인 뇌파는 뇌의 신경세포에서 끊임없이 발생하는 전기활동으로, 대뇌피질의 피질을 덮고 있는 두피 위에서 발생한다. 두피 위에 전극을 부착하고, 두뇌에서 발생된 전기신호를 뇌파계에 입력시켜 시간에 따른 전위를 기록해서 얻는 결과물을 뇌파 혹은 뇌전도(electroencephalogram, EEG)라고 하는데, 뇌파는 시시각각으로 변화하는 뇌 활동의 변동을 시공간적으로 기록할 수 있고, 비침습적, 연속적으로 간단하게 뇌의 기능을 측정할 수 있어서 뇌활동기록, 질병진단, 수면연구, 심리치료와 같은 인지과학, 의학, 약학 분야에서 폭넓게 활용되고 있다.EEG, one of the biomarkers that evaluate the function of health functional foods, is an electric activity that occurs constantly in the neurons of the brain and occurs on the scalp that covers the cortex of the cerebral cortex. Electroencephalogram (EEG) is an electroencephalogram (EEG) result obtained by attaching an electrode on the scalp and inputting electrical signals generated from the brain into the brain wave system and recording the potential according to time. Can be recorded in spatiotemporal and noninvasive, continuous and simple to measure the function of the brain, and thus widely used in cognitive science, medicine, and pharmacy such as brain activity record, disease diagnosis, sleep research, and psychotherapy.
인간의 뇌파는 주로 5~300 μV의 진폭과 0~60 Hz 사이의 주파수를 갖는데 주파수의 범위에 따라 델타(delta)파 (0.5~3 Hz), 세타(theta)파 (4~7 Hz), 알파(alpha)파 (8~13 Hz), 베타(beta)파 (14~30 Hz), 감마(gamma)파(30 Hz 이상)로 구분한다. 알파파를 기준으로 알파파보다 주파수가 작은 델타파와 세타파를 서파(slow wave)라고 하고, 알파파보다 주파수가 큰 베타파와 감마파를 속파(fast wave)라고 한다. 서파는 진폭이 높고 수면 기간에나 뇌의 활동이 저하되었을 때 나타나고, 속파는 진폭이 낮고 뇌의 활동이 촉진되었을 때 주로 나타나는 것으로 알려져 있다.Human brainwaves have amplitudes of 5 ~ 300 μV and frequencies between 0 and 60 Hz. Delta waves (0.5 ~ 3 Hz), theta waves (4-7 Hz) It is divided into alpha (8 ~ 13 Hz), beta (14 ~ 30 Hz) and gamma wave (30 Hz and above). A slow wave is a delta wave and a seta wave having a smaller frequency than an alpha wave based on an alpha wave, and a beta wave and a gamma wave having a larger frequency than an alpha wave are called a fast wave. It is known that the sweater appears when the amplitude is high and the activity of the brain is decreased during the sleeping period, and the slow wave is low and the brain activity is promoted.
알파파는 기본파이며 주파수는 8~13 Hz, 진폭은 10~150 μV로 정상 성인의 각성, 안정, 폐안 상태에서 주로 발생하는데 식품의약품안전처의 건강기능식품 기능성 평가 가이드에는 신체건강한 피험자를 대상으로 뇌파측정 시 알파파가 통계학적으로 유의성있게 증가할 경우 긴장완화에 도움을 줄 수 있다고 기술되어 있다.The alpha wave is a fundamental wave with a frequency of 8 ~ 13 Hz and an amplitude of 10 ~ 150 μV. It occurs mainly in arousal, stabilization, and closed state of normal adult. The Health Functional Food Functional Evaluation Guide of the Food and Drug Administration It is stated that a statistically significant increase in alpha waves in EEG measurements may help to relieve tension.
국내에서 블루베리향의 향료는 다양한 식품의 제조에 이용되고 있으나 블루베리 향료 조성물과 이의 제조방법 그리고 블루베리 향료 조성물이 두뇌 활동에 어떠한 영향을 미치는지에 대해서는 보고된 바가 없는 실정이다. 이에 본 발명에서는 트리아세틴(triacetine), 프로필렌 글리콜(propylene glycol), 라스베리 케톤(raspberry ketone), 에틸 말톨(ethyl maltol), 에틸 부티레이트(ethyl butyrate), 트리에틸 시트레이트(triethyl citrate), 아세트산(acetic acid) 등 총 26개의 화합물로 구성된 블루베리향 향료를 조향하고, 이를 피험자에게 흡입하도록 한 다음 뇌파를 측정하였을 때 좌측과 우측 전전두엽, 좌측과 우측 전두엽, 그리고 우측 측두엽에서 RFA(Relative Fast Alpha power spectrum)가 증가되고, 좌측과 우측 전전두엽과 좌측과 우측 전두엽에서 AFA(Absolute Fast Alpha power spectrum)가 증가되며, 우측 두정엽에서 AT(Absolute Theta power spectrum)가 증가되는 것이 관찰되어, 블루베리향 향료가 긴장 완화 효과를 가짐을 확인하였다.In Korea, blueberry flavors are used in various foods. However, there is no report on the influence of blueberry flavoring composition, its preparation method and blueberry flavoring composition on brain activity. Accordingly, the present invention provides a process for producing a poly (ethylene glycol), which comprises reacting triacetine, propylene glycol, raspberry ketone, ethyl maltol, ethyl butyrate, triethyl citrate, acid, and blueberry fragrances composed of 26 compounds were inhaled into the subject, and then measured by EEG. The left and right frontal lobes, left frontal and right frontal lobes, and right temporal lobes were RFA (Relative Fast Alpha power spectrum ), Increased Absolute Fast Alpha power spectrum (AFA) in the left and right prefrontal and left and right frontal lobes, and increased AT (Absolute Theta power spectrum) in the right parietal lobe. It was confirmed that it had mitigation effect.
한편, 한국등록특허 제0423885호에는 '블루베리 과즙과 알파파 증진 음료용 조성물을 함유하는 음료'가 개시되어 있으나, 블루베리향 향료가 뇌파에 영향을 미쳐 긴장완화 효과를 가지는 것에 대해서는 기재된 바가 없다.On the other hand, Korean Patent No. 0423885 discloses a 'beverage containing a blueberry juice and a composition for promoting an alpha-brewer', but it has not been described that a blueberry flavoring has an effect on a brain wave and has a relaxation effect .
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 트리아세틴(triacetine)을 비롯한 26개의 화합물을 이용하여 블루베리향이 나는 조합향료를 조향하였고, 향취의 소비자 선호도가 높은 1종의 향료 조성물을 이용하여 뇌파 변화를 분석한 결과, 본 발명의 블루베리향 향료 조성물이 좌측과 우측 전전두엽, 좌측과 우측 전두엽, 그리고 우측 측두엽에서 RFA(Relative Fast Alpha power spectrum)의 증가를, 좌측 및 우측 전전두엽과 좌측 및 우측 전두엽에서 AFA(Absolute Fast Alpha power spectrum)의 증가를, 그리고 우측 두정엽에서 AT(Absolute Theta power spectrum)의 증가를 유도하는 것을 확인함으로써, 본 발명을 완성하였다.SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and the present inventors have made intensive studies to provide a perfume composition which is prepared by using 26 compounds including triacetine and steering a blueberry- The results showed that the blueberry fragrance composition of the present invention increased the relative fast alpha power spectrum (RFA) in the left and right prefrontal regions, the left and right frontal lobes, and the right temporal lobe, Confirming that the increase of Absolute Fast Alpha power spectrum (AFA) in the left and right frontal lobes and the increase of AT (Absolute Theta power spectrum) in the right parietal lobe lead to completion of the present invention.
상기 과제를 해결하기 위해, 본 발명은 트리아세틴(triacetine), 프로필렌 글리콜(propylene glycol), 라스베리 케톤(raspberry ketone), 에틸 말톨(ethyl maltol), 바닐린(vanillin), 말톨(maltol), 에틸 부티레이트(ethyl butyrate), 이소아밀 아세테이트(isoamyl acetate), 트리에틸 시트레이트(triethyl citrate), 아세트산(acetic acid), 에틸 아세테이트(ethyl acetate), 아세탈(acetal), 에틸 락테이트(ethyl lactate), 젖산(lactic acid), 이소아밀 알콜(isoamyl alcohol), 디메틸 벤질 카비닐 부티레이트(dimethyl benzyl carbinyl butyrate), 벤질 아세테이트(benzyl acetate), 부틸 아세테이트(butyl acetate), 에틸 프로피오네이트(ethyl propionate), 프로필 아세테이트(propyl acetate), 벤질 알코올(benzyl alcohol), 에틸 바닐린(ethyl vanillin), 알파 이오논(alpha ionone), 제라닐 아세테이트(geranyl acetate), 감마-운데카락톤(gamma-undecalactone) 및 부탄올(butanol)을 유효성분으로 함유하는 긴장완화용 블루베리향 향료 조성물을 제공한다.In order to solve the above-mentioned problems, the present invention relates to a process for the preparation of a pharmaceutical composition containing triacetine, propylene glycol, raspberry ketone, ethyl maltol, vanillin, maltol, ethyl butyrate ethyl butyrate, isoamyl acetate, triethyl citrate, acetic acid, ethyl acetate, acetal, ethyl lactate, lactic acid, isoamyl alcohol, dimethyl benzyl carbinyl butyrate, benzyl acetate, butyl acetate, ethyl propionate, propyl acetate, propyl acetate, propyl acetate, acetate, benzyl alcohol, ethyl vanillin, alpha ionone, geranyl acetate, gamma-undecalactone and butano (butano) l) as an active ingredient.
또한, 본 발명은 상기 향료 조성물을 포함하는 긴장완화용 건강기능식품을 제공한다.In addition, the present invention provides a health functional food for relaxation comprising the above-mentioned perfume composition.
또한, 본 발명은 상기 향료 조성물을 포함하는 긴장완화용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for relaxation comprising the perfume composition.
본 발명의 블루베리향 향료 조성물은 향료 흡입을 통해, 좌측 및 우측 전전두엽, 좌측 및 우측 전두엽, 그리고 우측 측두엽에서 RFA의 증가를 유도하고, 좌측 및 우측 전전두엽과 좌측 및 우측 전두엽에서 AFA의 증가를 유도하며, 우측 두정엽에서 AT의 증가를 유도하여 긴장 완화 효과를 얻을 수 있다. 또한, 본 발명의 블루베리향 향료 조성물은 향장 향료(fragrance)와 식품향료(flavor) 원료뿐만 아니라, 식품에 첨가하여 긴장 완화를 유도하는 기능의 뉴로푸드(NeuroFood)의 개발에 사용될 수 있다.The blueberry flavoring compositions of the present invention induce an increase in RFA in the left and right prefrontal, left and right frontal lobes, and right temporal lobe via perfume inhalation and induce an increase in AFA in the left and right prefrontal and left and right frontal lobes And an increase in AT is induced in the right parietal lobe to obtain a relaxation effect. In addition, the blueberry flavoring composition of the present invention can be used not only for flavor fragrance and food flavor ingredients, but also for the development of NeuroFood capable of inducing relaxation by adding to foods.
도 1은 뇌파 측정을 위해 인간의 두뇌에 전극을 붙이는 부위를 제시한 10-20 국제표준 전극부착법을 보여주는 사진이다.
도 2는 피험자의 두뇌에 EGG용 모자를 씌우고 뇌파를 측정하는 모습을 보여주는 사진이다.
도 3은 블루베리향 향료 흡입 전(좌측)과 흡입 중(우측)의 RFA(relative fast alpha power spectrum) 변화를 보여주는 뇌지도 맵핑 결과이다.
도 4는 블루베리향 향료 흡입 전(좌측)과 흡입 중(우측)의 AFA(absolute fast alpha power spectrum) 변화를 보여주는 뇌지도 맵핑 결과이다.
도 5는 블루베리향 향료 흡입 전(좌측)과 흡입 중(우측)의 AT(absolute theta power spectrum) 변화를 보여주는 뇌지도 맵핑 결과이다.FIG. 1 is a photograph showing a 10-20 international standard electrode attaching method showing a region where an electrode is attached to a human brain for EEG measurement.
FIG. 2 is a photograph showing an EGG cap placed on a subject's brain and measuring brain waves.
FIG. 3 shows the brain map mapping results showing changes in relative fast alpha power spectrum (RFA) before inhalation (left) and inhalation (right) of blueberry perfume.
FIG. 4 is a map of a brain map showing changes in absolute fast alpha power spectrum (AFA) before inhalation (left side) and inhalation (right side) of blueberry perfume.
Figure 5 is a map of the brain map showing changes in AT (absolute theta power spectrum) before inhalation (left) and inhalation (right) of blueberry perfume.
본 발명의 목적을 달성하기 위하여, 본 발명은 트리아세틴(triacetine), 프로필렌 글리콜(propylene glycol), 라스베리 케톤(raspberry ketone), 에틸 말톨(ethyl maltol), 바닐린(vanillin), 말톨(maltol), 에틸 부티레이트(ethyl butyrate), 이소아밀 아세테이트(isoamyl acetate), 트리에틸 시트레이트(triethyl citrate), 아세트산(acetic acid), 에틸 아세테이트(ethyl acetate), 아세탈(acetal), 에틸 락테이트(ethyl lactate), 젖산(lactic acid), 이소아밀 알콜(isoamyl alcohol), 디메틸 벤질 카비닐 부티레이트(dimethyl benzyl carbinyl butyrate), 벤질 아세테이트(benzyl acetate), 부틸 아세테이트(butyl acetate), 에틸 프로피오네이트(ethyl propionate), 프로필 아세테이트(propyl acetate), 벤질 알코올(benzyl alcohol), 에틸 바닐린(ethyl vanillin), 알파 이오논(alpha ionone), 제라닐 아세테이트(geranyl acetate), 감마-운데카락톤(gamma-undecalactone) 및 부탄올(butanol)을 유효성분으로 함유하는 긴장완화용 블루베리향 향료 조성물을 제공한다.In order to accomplish the object of the present invention, the present invention provides a process for the production of a pharmaceutical composition comprising triacetine, propylene glycol, raspberry ketone, ethyl maltol, vanillin, maltol, ethyl But are not limited to, ethyl butyrate, isoamyl acetate, triethyl citrate, acetic acid, ethyl acetate, acetal, ethyl lactate, lactic acid, isoamyl alcohol, dimethyl benzyl carbinyl butyrate, benzyl acetate, butyl acetate, ethyl propionate, propyl acetate propyl acetate, benzyl alcohol, ethyl vanillin, alpha ionone, geranyl acetate, gamma-undecalactone, and butane (EN) Disclosed is a blueberry perfume composition for relaxation containing butanol as an active ingredient.
본 발명의 일 구현 예에 따른 상기 블루베리향 향료 조성물은 구체적으로,The blueberry flavoring composition according to one embodiment of the present invention specifically includes,
트리아세틴 79.8~80.5 중량%, 프로필렌 글리콜 8~12 중량%, 라스베리 케톤 0.5~1.5 중량%, 에틸 말톨 0.95~1.05 중량%, 바닐린 0.17~0.23 중량%, 말톨 0.15~0.25 중량%, 에틸 부티레이트 0.8~1.2 중량%, 이소아밀 아세테이트 0.8~1.2 중량%, 트리에틸 시트레이트 0.8~1.2 중량%, 아세트산 0.5~1.5 중량%, 에틸 아세테이트 0.5~1.0 중량%, 아세탈 0.7~0.9 중량%, 에틸 락테이트 0.35~0.45 중량%, 젖산 0.55~0.65 중량%, 이소아밀 알콜 0.35~0.45 중량%, 디메틸 벤질 카비닐 부티레이트 0.09~0.11 중량%, 벤질 아세테이트 0.09~0.11 중량%, 부틸 아세테이트 0.075~0.085 중량%, 에틸 프로피오네이트 0.09~0.11 중량%, 프로필 아세테이트 0.09~0.11 중량%, 벤질 알코올 0.09~0.11 중량%, 에틸 바닐린 0.01~0.03 중량%, 알파 이오논 0.03~0.05 중량%, 제라닐 아세테이트 0.015~0.025 중량%, 감마-운데카락톤 0.01~0.03 중량% 및 부탄올 0.015~0.025 중량%를를 함유하는 것일 수 있으며, 더욱 구체적으로는Wherein the emulsifier comprises 79.8 to 80.5% by weight of triacetin, 8 to 12% by weight of propylene glycol, 0.5 to 1.5% by weight of raspberry ketone, 0.95 to 1.05% by weight of ethyl maltol, 0.17 to 0.23% by weight of vanillin, 0.15 to 0.25% By weight of ethyl acetate, 0.7 to 0.9% by weight of acetal, 0.35 to 0.9% by weight of ethyl lactate, 0.8 to 1.2% by weight of isoamyl acetate, 0.8 to 1.2% by weight of triethyl citrate, 0.75 to 0.65 wt% of lactic acid, 0.35 to 0.45 wt% of isoamyl alcohol, 0.09 to 0.11 wt% of dimethylbenzylcarbylbutyrate, 0.09 to 0.11 wt% of benzyl acetate, 0.075 to 0.085 wt% of butyl acetate, 0.09-0.11% by weight of propylene glycol, 0.09-0.11% by weight of propyl acetate, 0.09-0.11% by weight of benzyl alcohol, 0.01-0.03% by weight of ethyl vanillin, 0.03-0.05% by weight of alphaironone, 0.015-0.025% by weight of geranyl acetate, 0.01 to 0.03% by weight undecalactone and 0.015 to 0.025% , And more specifically,
트리아세틴 80 중량%, 프로필렌 글리콜 10 중량%, 라스베리 케톤 1.0 중량%, 에틸 말톨 1.0 중량%, 바닐린 0.20 중량%, 말톨 0.20 중량%, 에틸 부티레이트 1.0 중량%, 이소아밀 아세테이트 1.0 중량%, 트리에틸 시트레이트 1.0 중량%, 아세트산 1.0 중량%, 에틸 아세테이트 0.7 중량%, 아세탈 0.8 중량%, 에틸 락테이트 0.4 중량%, 젖산 0.6 중량%, 이소아밀 알콜 0.4 중량%, 디메틸 벤질 카비닐 부티레이트 0.1 중량%, 벤질 아세테이트 0.1 중량%, 부틸 아세테이트 0.08 중량%, 에틸 프로피오네이트 0.1 중량%, 프로필 아세테이트 0.1 중량%, 벤질 알코올 0.1 중량%, 에틸 바닐린 0.02 중량%, 알파 이오논 0.04 중량%, 제라닐 아세테이트 0.02 중량%, 감마-운데카락톤 0.02 중량% 및 부탄올 0.02 중량%를 함유하는 것일 수 있으나, 이에 제한되지 않는다.A mixture of 80% by weight of triacetin, 10% by weight of propylene glycol, 1.0% by weight of raspberry ketone, 1.0% by weight of ethyl maltol, 0.20% by weight of vanillin, 0.20% by weight of maltol, 1.0% by weight of ethyl butyrate, A mixture of 1.0% by weight of lactate, 1.0% by weight of acetic acid, 0.7% by weight of ethyl acetate, 0.8% by weight of acetal, 0.4% by weight of ethyl lactate, 0.6% by weight of lactic acid, 0.4% by weight of isoamyl alcohol, 0.1% by weight of ethyl acetate, 0.1% by weight of butyl acetate, 0.1% by weight of ethyl propionate, 0.1% by weight of propyl acetate, 0.02% by weight of ethyl vanillin, 0.04% by weight of alphaironone, 0.02% by weight of geranyl acetate, 0.02% by weight of gamma-undecalactone, and 0.02% by weight of butanol.
본 발명의 상기 블루베리향 향료 조성물은, 좌측 및 우측 전전두엽, 좌측 및 우측 전두엽, 그리고 우측 측두엽에서 RFA(relative fast alpha power spectrum))의 증가를 유도하고, 좌측 및 우측 전전두엽과 좌측 및 우측 전두엽에서 AFA(absolute fast alpha power spectrum)의 증가를 유도하며, 우측 두정엽에서 AT(absolute theta power spectrum)의 증가를 유도하여 긴장완화 효과를 나타내는 것을 특징으로 한다.The blueberry fragrance composition of the present invention induces an increase in relative fast alpha power spectrum (RFA) in the left and right prefrontal regions, the left and right frontal lobes, and the right temporal lobe, and the left and right prefrontal and left and right frontal lobes And increases absolute absolute alpha power spectrum (AFA) and induces an increase in AT (absolute theta power spectrum) in the right parietal lobe to exhibit a relaxation effect.
RFA는 전체에서 fast alpha파의 비율을 의미하여 AFA는 fast alpha파의 절대파워를 뜻하는 것으로, 상기 RFA 및 AFA의 증가는 블루베리향 자극(향 흡입)에 의해 뇌에서 긴장을 완화시키는 것으로 알려진 fast alpha파가 증가했음을 의미하는 것이다. AT 파워스펙트럼은 theta파 영역의 절대 파워스펙트럼 값을 의미하는데 theta파는 조용한 상태의 육체, 감정 및 사고 활동과 관련이 있으며, 주의각성을 시켜 문제해결의 아이디어를 제공하는 것으로 알려져 있으며, 인간의 깊은 통찰과 관련이 있고 창의적인 생각이나 문제해결능력이 고조되는 것과 관련이 있으므로 유쾌하고 이완된 기분과 극단적인 각성과도 관련이 있고 명상 상태에서 출현하는 것으로 알려져 있는 뇌파이다. 따라서, 상기와 같은 뇌파 변화를 통해 본 발명의 블루베리향 향료 조성물의 흡입은 긴장완화의 효과를 유도할 수 있음을 알 수 있다.RFA refers to the ratio of fast alpha wave in total, and AFA means absolute power of fast alpha wave. The increase of RFA and AFA is known to relieve tension in the brain by blueberry stimulation (incense suction). This means that the fast alpha wave has increased. The AT power spectrum refers to the absolute power spectral value of theta wave field, which is related to the quiet state of physical, emotional, and thought activities, and is known to provide an idea of problem solving by awakening the attention, And related to the rise of creative thinking and problem-solving abilities, it is associated with pleasant, relaxed moods and extreme arousal, and is known to occur in meditation. Thus, it can be seen that the inhalation of the blueberry flavoring composition of the present invention through the above-described EEG changes can induce the effect of relaxation.
상기 향료 조성물은 향수를 포함하는 화장용품, 목욕비누를 포함하는 비누세정용품, 유리 크리너를 포함하는 실내청소용품, 자동차용 방향제를 포함하는 방향용품, 허브타입 입욕제를 포함하는 목욕용품, 문구류를 포함하는 향기상품, 오피스용 방향제를 포함하는 환경용품 또는 합성수지를 포함하는 공업용품을 제조하는데 사용할 수 있다.The perfume composition may include cosmetics including perfumes, soap cleansing products including bath soaps, indoor cleaning products including glass cleaners, aroma products including car perfumes, bath products including herbal bath salts, stationery Such as perfumes, fragrances, perfumes for offices, perfumes for office use, or industrial products containing synthetic resins.
상기 향료 조성물의 제형은 특별하게 제한되지 않지만, 분말, 과립, 액상 스프레이, 고형 및 젤 타입의 제형 중에서 선택된 어느 하나일 수 있다. The formulation of the perfume composition is not particularly limited, but may be any one selected from powders, granules, liquid spray, solid and gel type formulations.
또한, 본 발명은 본 발명의 블루베리향 향료 조성물을 포함하는 긴장완화용 건강기능식품을 제공한다.The present invention also provides a health functional food for relaxation comprising the blueberry flavoring composition of the present invention.
상기 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 및 천연 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. The health functional food may contain various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, colorants and enhancers (cheese, chocolate etc.), pectic acid and its salts, alginic acid and its salts, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices and vegetable drinks. These components may be used independently or in combination.
본 발명의 건강기능식품은 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. The health functional food of the present invention may contain various flavors or natural carbohydrates as an additional ingredient. The natural carbohydrates are sugar saccharides such as monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like.
또한, 본 발명은 본 발명의 블루베리향 향료 조성물을 포함하는 긴장완화용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for relaxation comprising the blueberry flavoring composition of the present invention.
상기 화장료 조성물은 유연화장수, 수렴화장수, 영양화장수, 영양로션, 영양에센스, 영양크림, 마사지크림, 에센스, 아이크림, 아이에센스, 클렌징크림, 클렌징폼, 클렌징워터, 팩, 젤, 파우더, 메이크업베이스, 바디로션, 바디크림, 바디오일, 바디에센스, 로션, 연고, 겔, 크림, 패취 및 분무제로 이루어진 군에서 선택되는 제형을 갖는 것이 바람직하지만 이에 한정하지 않는다.The cosmetic composition of the present invention can be used for cosmetics such as softening lotion, convergent lotion, nutritional lotion, nutrition lotion, nutrition essence, nutritional cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing foam, cleansing water, , A body lotion, a body cream, a body oil, a body essence, a lotion, an ointment, a gel, a cream, a patch, and a spray.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
실시예 1. 시료 확보Example 1. Sample preparation
본 발명에서 사용된 블루베리향 향료를 만드는데 사용된 트리아세틴(triacetine), 프로필렌 글리콜(propylene glycol), 라스베리 케톤(raspberry ketone), 에틸 말톨(ethyl maltol), 바닐린(vanillin), 말톨(maltol), 에틸 부티레이트(ethyl butyrate), 이소아밀 아세테이트(isoamyl acetate), 트리에틸 시트레이트(triethyl citrate), 아세트산(acetic acid), 에틸 아세테이트(ethyl acetate), 아세탈(acetal), 에틸 락테이트(ethyl lactate), 젖산(lactic acid), 이소아밀 알콜(isoamyl alcohol), 디메틸 벤질 카비닐 부티레이트(dimethyl benzyl carbinyl butyrate), 벤질 아세테이트(benzyl acetate), 부틸 아세테이트(butyl acetate), 에틸 프로피오네이트(ethyl propionate), 프로필 아세테이트(propyl acetate), 벤질 알코올(benzyl alcohol), 에틸 바닐린(ethyl vanillin), 알파 이오논(alpha ionone), 제라닐 아세테이트(geranyl acetate), 감마-운데카락톤(gamma-undecalactone) 및 부탄올(butanol)은 서울 소재 푸드아로마 사에서 제공하였다.Propylene glycol, raspberry ketone, ethyl maltol, vanillin, maltol, xanthan gum, and the like, which are used to make the blueberry flavoring used in the present invention, But are not limited to, ethyl butyrate, isoamyl acetate, triethyl citrate, acetic acid, ethyl acetate, acetal, ethyl lactate, But are not limited to, lactic acid, isoamyl alcohol, dimethyl benzyl carbinyl butyrate, benzyl acetate, butyl acetate, ethyl propionate, But are not limited to, propyl acetate, benzyl alcohol, ethyl vanillin, alpha ionone, geranyl acetate, gamma-undecalacto ne) and butanol were provided by Food Aroma Company of Seoul, Korea.
본 실시예에서 연구용 시료는 제공 받은 즉시 4℃의 냉장고에 보관하면서 블루베리향 향료 조향에 사용하였다.In the present example, the samples for research were used for steering blueberry flavoring while being stored in a refrigerator at 4 ° C as soon as they were provided.
실시예 2. 블루베리향 향료 개발 및 선호도 조사Example 2. Development and Preference Survey of Blueberry Scent
2-1. 블루베리향 향료 조향2-1. Blueberry incense spice steering
블루베리향 향료를 조향하기 위해 상기 실시예 1에 언급된 화합물들을 하기 표 1과 같이 혼합하여 8종의 조합 항료를 개발하였다.To control the blueberry flavoring, the compounds mentioned in Example 1 were mixed as shown in the following Table 1 to develop eight combined flavors.
(gamma-undecalactone)Gamma-undecalactone
(gamma-undecalactone)
(geranyl acetate)Geranyl acetate
(geranyl acetate)
(propyl acetate)Propyl acetate
(propyl acetate)
(ethyl propionate)Ethyl propionate
(ethyl propionate)
(butyl acetate)Butyl acetate
(butyl acetate)
(benzyl acetate)Benzyl acetate
(benzyl acetate)
(dimethyl benzyl carbinyl butyrate)Dimethylbenzylcarbylbutyrate
(dimethyl benzyl carbinyl butyrate)
(isoamyl alcohol)Isoamyl alcohol
(isoamyl alcohol)
(ethyl acetate)Ethyl acetate
(ethyl acetate)
(triethyl citrate)Triethyl citrate
(triethyl citrate)
(isoamyl acetate)Isoamyl acetate
(isoamyl acetate)
(ethyl butyrate)Ethyl butyrate
(ethyl butyrate)
2-2. 블루베리향 조합향료 1~8에 대한 소비자 선호도 조사2-2. Consumer preference survey on blueberry flavor combination fragrance 1-8
상기에서 조향된 조합향료 1~8에 대한 소비자들의 반응을 알아보기 위하여 소비자 선호도 조사를 실시하였다. 향에 대한 후각훈련이 되어 있는 강원대학교 Rose of Sharon 패널 10명을 대상으로, 조합향료 1~8의 원액을 시향지(0.5 cm x 5 cm)에 적신 다음 패널의 코로부터 5 cm 위치에 놓고 향을 맡게 한 다음 1~10 후각 선호도 시스템을 이용하여 가장 선호하는 향료에 10점을, 그리고 가장 싫어하는 향료에 1점을 주도록 하였다. 선호도 조사 결과는 하기의 표 2에 나타내었다. 소비자들의 선호도가 가장 높았던 것은 블루베리향 조합향료 8이었으며 평균값은 9.10이었다. 나머지 7종의 조합향료는 평균값이 블루베리향 향료 8과 비교하여 현저히 낮았기에 실시예 3의 블루베리향 향료가 뇌파에 미치는 영향에서는 블루베리향 향료 8을 가지고 수행하였다.Consumer preference studies were conducted to investigate consumer responses to the combined fragrances 1-8. 10 of Rose of Sharon panel of Kangwon National University, which had olfactory training for fragrance, were soaked with a sponge (0.5 cm x 5 cm) of combined fragrance 1 ~ 8, placed 5 cm from the nose of the panel, And then given 10 points to the most preferred flavor and 1 point to the least favorite flavor using the 1 to 10 olfactory preference system. The results of the preference survey are shown in Table 2 below. The highest consumer preference was blueberry fragrance 8 and the average value was 9.10. The average value of the other seven combined perfumes was significantly lower than that of blueberry flavoring 8, so that the effect of blueberry flavoring of Example 3 on EEG was performed with blueberry flavoring 8.
실시예 3. 블루베리향 향료가 뇌파에 미치는 영향 분석Example 3: Analysis of effect of blueberry flavoring on EEG
실시예 2를 통해 소비자 선호도가 가장 높았던 블루베리향 조합향료 8(이하 '블루베리향 향료')을 선정하였고, 블루베리향 향료가 인간의 뇌활동에 어떠한 영향을 주었는지를 알고자 뇌파를 측정하였다.The blueberry flavor combination fragrance 8 (hereinafter, "blueberry flavor fragrance"), which had the highest consumer preference through Example 2, was selected, and the brain waves were measured by knowing how the blueberry flavoring had an effect on the human brain activity Respectively.
뇌파 측정은 최대한 잡음이 혼입되지 않은 온도 23℃, 습도 50%가 유지되는 32.4 m2 크기의 실험실에서 남, 녀 각각 10명 총 20명의 피험자를 대상으로 수행하였다. 뇌파측정을 위해 사용한 뇌파측정기는 QEEG-8 시스템(LXE3208, LAXTHA Inc. 한국)이었으며, 피험자의 뇌파신호 측정은 LAXTHA사의 데이터 수집 장비 및 분석 프로그램(Telescan)을 이용하였다. 피험자들에게 10~20 국제표준전극 부착법(도 1)을 이용하여 8개의 접지전극을 뇌파전용 Electro-Gel(Electro-Cap Internationals, Inc. 미국)을 사용하여 좌측과 우측 전전두엽(Fp1, Fp2), 좌측과 우측 전두엽(F3, F4), 좌측과 우측 측두엽(T3, T4), 좌측과 우측 두정엽(P3, P4) 부분에 부착하고 오른쪽과 왼쪽 귓볼 뒷부분에도 각각 하나씩의 전극(CovidienTM)을 부착하였다(도 2). 블루베리향 향료 원액(100%)을 시향지(0.5 cm x 5 cm)에 적신 다음 피험자의 코로부터 5 cm 위치에 놓고 향을 맡게 한 다음 피험자가 눈을 감은 상태에서 향 흡입 전(무자극)과 흡입 상태(향 자극)로 하여 각각 45초씩 측정하였다.EEG measurements were performed on a total of 20 subjects, 10 of each male and female, in a laboratory of 32.4 m 2 in which the noise was not mixed and the temperature was maintained at 23 ° C and 50% humidity. The brain waves were measured using a QEEG-8 system (LXE3208, LAXTHA Inc. Korea). EEG data were collected using LAXTHA's data collection equipment and analysis program (Telescan). 8 electrodes were connected to the left and right prefrontal cords (Fp1, Fp2) using Electro-Gel (Electro-Cap Internationals, Inc. USA) One electrode (Covidien ™ ) was attached to the left and right frontal lobes (F3 and F4), left and right temporal lobes (T3 and T4), left and right parietal lobes (P3 and P4) (Fig. 2). (100%) was soaked in a tissue paper (0.5 cm x 5 cm), placed at a position 5 cm from the nose of the subject, and the incense was taken. Then, And an inhalation state (fragrance stimulation).
뇌파측정을 통해 얻어진 데이터 중 전반부 5초와 후반부 10초의 데이터를 제외한 중간 30초간의 뇌파 데이터만을 추출하여 뇌파 일괄처리 프로그램(batch processing)으로 수행한 후, 통계분석 소프트웨어 프로그램인 SPSS(18.0 버전)를 이용하여 대응표본 T 검정을 수행하였다.Only EEG data of the middle 30 seconds except for the data of 5 seconds in the first half and 10 seconds in the latter half of the data obtained by EEG measurement were extracted and processed by batch processing of brain waves, and statistical analysis software program SPSS (version 18.0) To perform a corresponding sample T test.
본 실시예에서 블루베리향 향료의 흡입 전(무자극)과 흡입 중(향 자극)에 얻는 데이터 분석을 위한 뇌파 지표의 종류는 표 3에, 그리고 각 뇌파 지표의 의미는 표 4에 나타내었다.Table 3 shows the types of EEG indicators for data analysis obtained before inhalation (irritation) and during inhalation (incense stimulation) of blueberry flavoring in this example, and the meanings of the EEG indices are shown in Table 4.
본 실시예에서 블루베리향 향료 흡입 전(무자극)과 흡입 중(향 자극)에 뇌파를 측정하고 파워스펙트럼 분석을 한 결과 총 25개의 뇌파지표 중 RFA(relative fast alpha power spectrum), AFA(absolute fast alpha power spectrum) 및 AT (absolute theta power spectrum)만 통계학적으로 유의성이 있는 것으로 나타났다 (p<0.05). 나머지 22개의 파워스펙트럼은 차이가 발견되지 않았기 때문에 본 실시예에서는 기술하지 않기로 한다.In the present embodiment, EEG was measured before and after inhalation of blueberry flavoring (intact stimulation) and power spectral analysis was performed. As a result, the relative fast alpha power spectrum (RFA) fast alpha power spectrum and AT (absolute theta power spectrum) were statistically significant (p <0.05). The remaining 22 power spectra are not described in this embodiment because no difference is found.
블루베리향 향료의 흡입으로 20명 피험자들의 RFA 파워스펙트럼이 좌측 전전두엽(Fp1)과 우측 전전두엽(Fp2), 좌측 전두엽(F3)과 우측 전두엽(F4), 우측 측두엽(T4)에서 유의미하게 증가한 것으로 나타났는데 이와 같은 파워스펙트럼 변화는 하기 표 5에 그리고 이에 대한 뇌지도 맵핑(brain mapping) 결과는 도 3에 나타내었다. RFA는 뇌파 스펙트럼에서 전체 주파수 대역의 절대 파워를 기준으로 각 주파수의 절대파워를 비율로 계산한 값으로 fast alpha파 영역(11~13 Hz)을 전체 주파수 영역(4~50 Hz)으로 나누어준 상대적인 파워스펙트럼 값을 의미한다.The RFA power spectrum of 20 subjects was significantly increased in the left prefrontal (Fp1) and right prefrontal (Fp2), left frontal (F3), right frontal (F4), and right temporal (T4) The power spectral change is shown in Table 5 and the brain mapping result is shown in FIG. RFA is the ratio of the absolute power of each frequency based on the absolute power of the whole frequency band in the EEG spectrum. It is the relative frequency of the relative frequency divided by the entire frequency range (4 ~ 50 Hz) Power spectral value.
본 실시예에서 블루베리향 향료 흡입은 표 5에서와 같이 좌측 전전두엽(Fp1), 우측 전전두엽(Fp2), 좌측 전두엽(F3), 우측 전두엽(F4) 및 우측 측두엽(T4)에서 광범위하게 fast alpha파를 증가시켰으며 이를 통해 피험자들의 긴장이 완화되었을 것으로 판단되었다. 본 실시예에서 블루베리향 향료 흡입으로 자극받은 전전두엽은 전두피질의 비운동영역으로 인간에서 있어서 가장 뚜렷한 인지부위로 알려져 있으며 전체 피질의 1/3 정도를 차지하고 있다. 전전두엽은 활동의 시작, 계획, 핵심정보의 유지, 하나의 사고에서 다른 사고로의 세트 변화, 자신의 행동효과를 감시, 계획의 갈등요소 탐색 및 해결, 비효과적인 계획이나 행동의 억제와 같은 인지기능을 담당하는 것으로 알려져 있다. 그리고 전두엽은 뇌의 다른 부위들을 조절하는 영역으로 주의집중, 언어, 기억, 시공간 능력, 운동기능, 집행기능, 성격 및 정서, 감정인식, 추론과 판단, 행동계획, 의사결정 등 인간이 수행하는 대부분의 인지기능과 관련이 높다(Carter et al. (2009) The Human Brain Book. DK Publishing Co. Ltd. p.256). 또한 블루베리향 향료 흡입은 우측 측두엽(T4) 부위의 RFA 파워스펙트럼을 증가시켰는데 우측 측두엽(T4) 부위는 개인적인 기억과 언어를 담당하는 기능을 하며 활성화 되었을 때 무엇인가를 깨닫고 창의력이 발휘되는 것으로 보고된 바가 있다(박동희 (2008) 동양의학의 뜸 자극방식에 따른 EEG 변화에 대한 분석. 동의대학교 석사학위논문).As shown in Table 5, inhalation of blueberry flavoring in the present embodiment is broadly classified into fast alpha (Fp1), fulminant (Fp2), left frontal (Fp2), left frontal (F3), right frontal And the tensions of the subjects were alleviated. In the present example, the prefrontal cortex stimulated by the inhalation of blueberry flavor is known as the non-motor area of the frontal cortex, which is known to be the most conspicuous cognitive part in human and occupies about 1/3 of the whole cortex. The prefrontal cortex can be used to initiate activities, plan, maintain key information, change sets from one thought to another, monitor their behavioral effects, explore and resolve conflicting elements of planning, and inhibit ineffective planning or behavior. Is known to be responsible for. And the frontal lobe is the area that controls other parts of the brain. It is the area where attention is focused, language, memory, space time ability, exercise function, executive function, personality and emotion, emotion recognition, reasoning and judgment, action plan, (Carter et al . (2009) The Human Brain Book, DK Publishing Co. Ltd. p.256). In addition, the inhalation of blueberry flavoring increased the RFA power spectrum of the right temporal lobe (T4) region. The right temporal lobe (T4) region functions as a personal memory and language, and when activated, realizes something and demonstrates its creativity (2008) Analysis of changes in EEG according to the moxibustion stimulation method of oriental medicine.
블루베리향 향료 흡입 전과 흡입 중의 뇌 전체에 대한 RFA의 변화를 시각적으로 확인하기 위하여 뇌지도 맵핑(brain mapping)을 수행한 결과, 좌측 전전두엽(Fp1), 우측 전전두엽(Fp2), 좌측 전두엽(F3) 및 좌측 전두엽(F3) 부위가 흡입 전 짙은 파란색에서 흡입 중에는 연한 녹색으로 변한 것을 확인할 수 있었으며, 우측 측두엽(T4) 부위가 흡입 전 옅은 황적색에서 흡입 중 짙은 적색으로 변한 것을 알 수 있었다(도 3).Brain mapping was performed to visualize the RFA changes before and after inhalation of the blueberry flavor perfume. The left prefrontal cortex (Fp1), the right prefrontal cortex (Fp2), the left frontal cortex (F3) And the left frontal lobe (F3) area was changed from deep blue to inhaled light green, and the right temporal lobe (T4) area changed from pale yellowish red to inhaled deep red before inhalation (Fig. 3) .
(Fp1)Left prefrontal cortex
(Fp1)
(Fp2)Right frontal lobe
(Fp2)
(F3)Left frontal lobe
(F3)
(F4)Right frontal lobe
(F4)
(T3)Left temporal lobe
(T3)
(T4)Right temporal lobe
(T4)
(P3)Left parietal lobe
(P3)
(P4)Right parietal lobe
(P4)
그리고 블루베리향 향료의 흡입으로 20명 피험자들의 AFA가 좌측 전전두엽(Fp1), 우측 전전두엽(Fp2), 좌측 전두엽(F3) 및 우측 전두엽(F4) 부위에서 유의미하게 증가한 것으로 나타났다. AFA 변화는 하기 표 6에 그리고 이에 대한 뇌지도 맵핑 결과는 도 4에 나타내었다. AFA는 fast alpha파의 증가에 따라 나타났는데, fast alpha파는 긴장을 완화시키는 것으로 알려져 있다. 블루베리향 향료 흡입으로 인지기능을 담당하는 뇌 부위에서 AFA가 증가하였다는 결과로부터 피험자들의 긴장이 완화되었다는 사실을 알 수 있다.AFA of 20 subjects showed a significant increase in the left prefrontal (Fp1), right prefrontal (Fp2), left frontal (F3) and right frontal (F4) areas by inhalation of blueberry flavor. The AFA changes are shown in Table 6 below and the brain map mapping results are shown in FIG. AFA has been associated with an increase in fast alpha waves, and fast alpha waves are known to relieve tension. The results of the increase in AFA in the brain area responsible for cognitive function by inhalation of blueberry flavor fragrance show that the subjects' tensions are relaxed.
블루베리향 향료를 흡입 전과 흡입 중의 뇌 전체에 대한 AFA의 변화를 시각적으로 확인하기 위하여 뇌지도 맵핑을 수행한 결과, 좌측 전전두엽(Fp1)과 우측 전전두엽(Fp2), 좌측 전두엽(F3)과 우측 전두엽(F4) 부위가 향료 흡입 전에는 옅은 파란색이었던 것이 흡입 중에는 연한 녹색으로 변한 것을 알 수 있었다(도 4).In order to visually confirm AFA changes before and after inhalation of blueberry flavorings, brain mapping was performed. The left frontal lobe (Fp1) and the right frontal lobe (Fp2), the left frontal lobe (F3) (F4) area was light blue before the perfume was inhaled, and turned to light green during inhalation (FIG. 4).
(Fp1)Left prefrontal cortex
(Fp1)
(Fp2)Right frontal lobe
(Fp2)
(F3)Left frontal lobe
(F3)
(F4)Right frontal lobe
(F4)
(T3)Left temporal lobe
(T3)
(T4)Right temporal lobe
(T4)
(P3)Left parietal lobe
(P3)
(P4)Right parietal lobe
(P4)
또한, 블루베리향 향료 흡입으로 20명 피험자들의 AT 파워스펙트럼이 우측 두정엽(P4)에서 증가하였다(표 7). AT 파워스펙트럼은 theta파 영역(4~8 Hz)의 절대 파워스펙트럼 값을 의미하는데 theta파는 조용한 상태의 육체, 감정 및 사고 활동과 관련이 있으며, 주의각성을 시켜 문제해결의 아이디어를 제공하는 것으로 알려져 있으며, 인간의 깊은 통찰과 관련이 있고 창의적인 생각이나 문제해결능력이 고조되는 것과 관련이 있으므로 유쾌하고 이완된 기분과 극단적인 각성과도 관련이 있고 명상 상태에서 출현하는 특징이 있다(인지영, 김종욱 (2014) 불교 명상을 통한 심신치유의 뇌과학적 이해. 불교학보 68:24-49).In addition, the AT power spectrum of 20 subjects was increased in the right parietal lobe (P4) by inhalation of blueberry flavoring (Table 7). The AT power spectrum refers to the absolute power spectral value of theta wave field (4 to 8 Hz), which is related to the quiet state of physical, emotional, and thought activities, and is known to provide an idea of problem solving And related to the deep insights of human beings and related to the rise of creative thinking and problem-solving abilities, there are also features related to pleasant and relaxed moods and extreme awakening, and appearing in meditation state (2014) Brain scientific understanding of mind and body healing through Buddhist meditation. Buddhist Journal 68: 24-49).
블루베리향 향료를 흡입 전과 흡입 중의 뇌 전체에 대한 AT 파워스펙트럼의 변화를 시각적으로 확인하기 위하여 뇌지도 맵핑을 한 결과, 우측 두정엽(P4) 부위가 향료 흡입 전에는 짙은 녹색이었던 것이 흡입 중에는 연한 녹색으로 변한 것을 알 수 있었다(도 5). In order to visually confirm the change of the AT power spectrum before and after the inhalation of the blueberry flavoring, brain mapping mapping showed that the right parietal region (P4) was dark green before inhalation, (Fig. 5).
(Fp1)Left prefrontal cortex
(Fp1)
(Fp2)Right frontal lobe
(Fp2)
(F3)Left frontal lobe
(F3)
(F4)Right frontal lobe
(F4)
(T3)Left temporal lobe
(T3)
(T4)Right temporal lobe
(T4)
(P3)Left parietal lobe
(P3)
(P4)Right parietal lobe
(P4)
상기의 결과들을 토대로, 본 발명의 블루베리 향료는 흡입을 통해 뇌파의 변화를 유도하여 긴장완화의 효과를 나타낼 수 있음을 알 수 있었다.Based on the above results, it was found that the blueberry flavoring of the present invention can induce a change of EEG through inhalation to show the effect of relaxation.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160119745A KR101855737B1 (en) | 2016-09-20 | 2016-09-20 | Aroma composition with buleberry flavor for relaxation and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160119745A KR101855737B1 (en) | 2016-09-20 | 2016-09-20 | Aroma composition with buleberry flavor for relaxation and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180031311A KR20180031311A (en) | 2018-03-28 |
KR101855737B1 true KR101855737B1 (en) | 2018-05-10 |
Family
ID=61901283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160119745A KR101855737B1 (en) | 2016-09-20 | 2016-09-20 | Aroma composition with buleberry flavor for relaxation and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101855737B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102606763B1 (en) | 2022-11-02 | 2023-11-29 | 연세대학교 산학협력단 | A Composition for Improving or Alleviating Stress-related Disorders Comprising Nerol Compound |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110959903A (en) * | 2019-09-12 | 2020-04-07 | 深圳雾芯科技有限公司 | Flavor composition and electronic cigarette liquid containing same |
CN111249182B (en) * | 2019-10-11 | 2021-03-02 | 深圳市越昌科技有限公司 | Tranquilizing composition and application thereof in perfume |
KR102152076B1 (en) * | 2019-10-16 | 2020-09-07 | 주식회사 센트프로 | Fragrance composition for improving concentration and method for preparing the same |
KR102294166B1 (en) * | 2019-10-16 | 2021-08-27 | 주식회사 센트프로 | Method for producing a perfume composition that improves the emotional comfort of the brain |
KR102294167B1 (en) * | 2019-10-16 | 2021-08-27 | 주식회사 센트프로 | Manufacturing method of perfume composition improving mental and physical stability |
GB2589585A (en) * | 2019-12-02 | 2021-06-09 | Judd Health Ltd | Improvements in weight control |
CN115777905B (en) * | 2022-09-21 | 2024-02-13 | 埃德玛香精(杭州)有限公司 | Honey peach essence and preparation process thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100620511B1 (en) * | 2005-06-27 | 2006-09-06 | 주식회사한국야쿠르트 | ALNUS JAPONICA COMPOSITION AS A beta;-SECRETASE INHIBITOR |
JP2006298915A (en) * | 2005-03-24 | 2006-11-02 | Showa Denko Kk | Chemical agent composition |
KR100676487B1 (en) * | 1999-12-17 | 2007-02-05 | 라이온 가부시키가이샤 | Liquid detergent composition |
KR101349592B1 (en) | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
-
2016
- 2016-09-20 KR KR1020160119745A patent/KR101855737B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100676487B1 (en) * | 1999-12-17 | 2007-02-05 | 라이온 가부시키가이샤 | Liquid detergent composition |
JP2006298915A (en) * | 2005-03-24 | 2006-11-02 | Showa Denko Kk | Chemical agent composition |
KR100620511B1 (en) * | 2005-06-27 | 2006-09-06 | 주식회사한국야쿠르트 | ALNUS JAPONICA COMPOSITION AS A beta;-SECRETASE INHIBITOR |
KR101349592B1 (en) | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102606763B1 (en) | 2022-11-02 | 2023-11-29 | 연세대학교 산학협력단 | A Composition for Improving or Alleviating Stress-related Disorders Comprising Nerol Compound |
Also Published As
Publication number | Publication date |
---|---|
KR20180031311A (en) | 2018-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101855737B1 (en) | Aroma composition with buleberry flavor for relaxation and uses thereof | |
KR101077018B1 (en) | Cosmetic Composition with Anti-stress and Relaxing Effect | |
WO2012165831A2 (en) | Aromatic composition having stress-relieving and relaxing effects and cosmetic composition containing same | |
JP2012246278A (en) | Psychic energizer and psychic energizer composition | |
KR101714543B1 (en) | Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component | |
KR102151761B1 (en) | Aquatic aroma composition for relaxation and enhancing concentration of human brain and uses thereof | |
Sayowan et al. | The harmonizing effects of citronella oil on mood states and brain activities | |
KR101434449B1 (en) | Natural Fragrance Composition Displaying Anti-tress Using an Essential Oil Extract of Torreya nucifera Leaf | |
KR102055499B1 (en) | Perfume composition for decreasing relative theta wave and relative alpha wave of brainwave containing essential oil of Chrysanthemum indicum L and use thereof | |
KR102060960B1 (en) | Aroma composition having fragrance of sensual luminous flower for brain pleasant and comfort | |
JPWO2020004182A1 (en) | Sleep improver | |
KR102060957B1 (en) | Deep forest mix aroma composition for enhancing concentration of human brain and uses thereof | |
KR101810228B1 (en) | A natural aromatic composition and a cosmetic composition containing the same | |
KR102060958B1 (en) | Tropical passion flower aroma composition for enhancing concentration of human brain and uses thereof | |
KR101533673B1 (en) | Perfume composition for expressing the fragrance of gardenia jasminoides Ellis for. Grandiflora Makino | |
KR102151758B1 (en) | Aromatic aroma composition for enhancing concentration of human brain and uses thereof | |
CN108078886A (en) | A kind of compound Thief zone moisturizing elite and its preparation process | |
KR101791217B1 (en) | A composition for enhancing concentration and memory containing Thuja orientalis oil extract as an active ingredient | |
KR20220090742A (en) | A foot massage composition for aromatherapy | |
KR101313255B1 (en) | Fragrance compound containing the essential oil from Heracleum moellendorffii | |
KR102538787B1 (en) | Composition for enhancing awakening and concentration of human brain and uses thereof | |
JPH11343497A (en) | Cosmetic | |
JP2020055826A (en) | Autonomic nerve regulator | |
KR101661120B1 (en) | Perfume composition for awakening effect or enhancing ability to concentration comprising essential oil of Magnolia Flos as an effective component | |
KR102597516B1 (en) | Fragrance composition for stress relief and psychological stability enhancement containing novel organic compounds as active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |